Infographic: Biosimilar Pegfilgrastim

Who will be the first manufacturer to succeed in gaining European or United States regulatory approval for a biosimilar pegfilgrastim product?

Related Content:

BusinessRegulatory

Milestone Approvals, Evolving PBM Models May Redefine the 2026 Biosimilar Landscape

Biosimilar Competition Linked to Lower Out-of-Pocket Costs for Medicare Patients

Eye on Pharma: Global Approvals, Launches, and Strategic Partnerships